Publications

CANVAS network publications as of September 2026

List of Publications

Title	All Authors	Publication Date
Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers.	Lapphra, K., Dobson, S., & Bettinger, J.A.	2010
Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine.	De Serres, G., Gariépy, M.-C., Coleman, B., Rouleau, I., McNeil, S., Benoît, M., McGeer, A., Ambrose, A., Needham, J., Bergeron, C., Grenier, C., Sleigh, K., Kallos, A., Ouakki, M., Ouhoummane, N., Stiver, G., Valiquette, L., McCarthy, A., & Bettinger, J.A.	2012
Rapid online identification of adverse events after influenza immunization in children by PCIRN’s National Ambulatory Network.	Bettinger, J.A., Vanderkooi, O.G., MacDonald, J., & Kellner, J.D.	2014
An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination	Wilson, K., Atkinson, K.M., Westeinde, J., Bell, C., Marty, K., Fergusson, D., Deeks, S.L., Crowcroft, N., & Bettinger, J.A.	2016
Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program	MacDougall, D.M., Langley, J.M., Li, L., Ye, L., MacKinnon-Cameron, D., Top, K.A., McNeil, S.A., Halperin, B.A., Swain, A., Bettinger, J.A., Dubé, E., De Serres, G., & Halperin, S.A.	2017
2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.	Bettinger, J.A., De Serres, G., Valiquette, L., Vanderkooi, O.G., Kellner, J.D., Coleman, B.L., Top, K.A., Isenor, J.E., & McCarthy, A.E.	2020
Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.	Ahmed, M.A., Naus, M., Singer, J., Valiquette, L., Coleman, B.L., De Serres, G., Vanderkooi, O.G., Top, K.A., Isenor, J.E., Kellner, J.D., McCarthy, A.E., & Bettinger, J.A.	2020
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study	Sadarangani, M., Soe, P., Shulha, H., Valiquette, L., Vanderkooi, O.G., Kellner, J.D., Muller, M.P., Top, K.A., Isenor, J.E., McGeer, A., Irvine, M., De Serres, G., Marty, K., & Bettinger, J.A.	2022
Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-Co-V-2 Infection from the Canadian National Vaccine Safety Network.	Bettinger, J.A., Irvine, M.A., Shulha, H.P., Valiquette, L., Muller, M.P., Vanderkooi, O.G., Kellner, J.D., Top, K.A., Sadarangani, M., McGeer, A., Isenor, J.E., Marty, K., Soe, P., & De Serres, G.	2022
A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.	Psihogios, A., Bota, A.B., Mithani, S.S., Greyson, D., Zhu, D.T., Fung, S.G., Wilson, S.E., Fell, D.B., Top, K.A., Bettinger, J.A., & Wilson, K.	2022
Surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada	Bettinger, J.A., Sadarangani, M., De Serres, G., Valiquette, L., Vanderkooi, O.G., Kellner, J.D., Muller, M.P., Top, K.A., Isenor, J.E., McGeer, A., & Marty, K.	2022
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial.	Bota, A.B., Bettinger, J.A., Sarfo-Mensah, S., Lopez, J., Smith, D.P., Atkinson, K., Bell, C., Marty, K., Serhan, M., Zhu, D., McCarthy, A., & Wilson, K.	2023
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara – Bavarian Nordic (MVA-BN) administered to a Canadian Population at risk of Mpox: A Canadian Immunization Research Network (CIRN) study.	Muller, M.P., Navarro, C., Wilson, S.E., Shulha, H.P., Naus, M., Lim, G., Padhi, S., McGeer, A., Finkelstein, M., Liddy, A., & Bettinger, J.A.	2023
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.	Top, K.A., Shulha, H.P., Muller, M.P., Valiquette, L., Vanderkooi, O.G., Kellner, J.D., Sadarangani, M., Irvine, M.A., McGeer, A., Isenor, J.E., Marty, K., Soe, P., De Serres, G., & Bettinger, J.A.	2024
Canadian Immunization Research Network. mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.	Soe, P., Wong, H., Naus, M., Muller, M.P., Vanderkooi, O.G., Kellner, J.D., Top, K.A., Sadarangani, M., Isenor, J.E., Marty, K., De Serres, G., Valiquette, L., McGeer, A., & Bettinger, J.A.	2024
Canadian Immunization Research Network. Impact of recruitment strategies on individual participation practices in the Canadian National Vaccine Safety Network: prospective cohort study	Soe, P., Sadarangani, M., Naus, M., Muller, M.P., Vanderkooi, O.G., Kellner, J.D., Top, K.A., Wong, H., Isenor, J.E., Marty, K., De Serres, G., Valiquette, L., McGeer, A., & Bettinger, J.A.	2024
Myocarditis/pericarditis after mRNA COVID-19 vaccination in children and adolescents reported to the Canadian National Vaccine Safety Network: A Canadian Immunization Research Network (CIRN) study.	Soe, P., Vanderkooi, O.G., Sadarangani, M., Naus, M., Muller, M.P., Kellner, J.D., Top, K.A., Wong, H., Isenor, J.E., Marty, K., Shulha, P.H., McGeer, A., De Serres, G., Valiquette, L., & Bettinger, J.A.	2024
Vaccine Safety Surveillance in Canada: Opportunities for Equity [Webinar]. CAIRE-NCCID Webinar	Top, K.A., Muller, M., Janjua, N., & Wilson, S.	2024
mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study	Soe, P., Vanderkooi, O.G., Sadarangani, M., Naus, M., Muller, M.P., Kellner, J.D., Top, K.A., Wong, H., Isenor, J.E., Marty, K., Shulha, H.P., De Serres, G., Valiquette, L., McGeer, A., & Bettinger, J.A.	2024
The Canadian National Vaccine Safety (CANVAS) network: Cross-sectional analysis of seasonal influenza vaccine safety in children during the 2013/2014 to 2019/2020 influenza seasons	Lopez, J.R., Vanderkooi, O.G., Kellner, J.D., Valiquette, L., De Serres, G., Top, K.A., Isenor, J., Muller, M.P., Naus, M., & Bettinger, J.A.	2025
Safety of co-administration of COVID-19 and seasonal influenza vaccines in individuals with autoimmune diseases from the Canadian National Vaccine Safety Network	Soe, P., Muller, M.P., Sadarangani, M., Kellner, J.D., Vanderkooi, O.G., Naus, M., Wong, H., Isenor, J.E., Marty, K., De Serres, G., Valiquette, L., McGeer, A., & Bettinger, J.A.	2025
Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network	Turner, C., Vanderkooi, O.G., Kellner, J.D., Shulha, H.P., Muller, M.P., Sadarangani, M., Isenor, J.E., Marty, K., Soe, P., Kiely, M., Valiquette, L., McGeer, A., & Bettinger, J.A.	2026
mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network	Muller, M.P., Soe, P., Shulha, H.P., Isenor, J.E., Valiquette, L., Sadarangani, M., Vanderkooi, O.G., Kellner, J.D., Top, K.A., De Serres, G., McGeer, A., Kiely, M., Marty, K., Irvine, M., & Bettinger, J.A.	2026
Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.	Viñeta Paramo, M., Kiely, M., Valiquette, L., Muller, M.P., McGeer, A., Isenor, J.E., Sadarangani, M., Kellner, J.D., Vanderkooi, O.G., Marty, K., Lavoie, P.M., & Bettinger, J.A.	2026
Safety of mRNA COVID-19 Vaccination during Pregnancy: Findings from Post-vaccination Follow-up Data from the Canadian National Vaccine Safety Network	Soe, P., Muller, M.P., Isenor, J.E., Valiquette, L., Vanderkooi, O.G., Kellner, J.D., Top, K.A., De Serres, G., McGeer, A., Kiely, M., Shulha, H.P., Irvine, M.A., Marty, K., Sadarangani, M., & Bettinger, J.A.	2026